🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06690099
Active, not recruiting Observational

Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women

NCT06690099 · tracked via the Priya Life Science USA tracker
Sponsor
Devyser Inc.
Phase
Observational
Started
2025-04-07
Last updated
2026-08-21

Condition(s) studied

Rhesus D GenotypePregnancy

Study summary

The purpose of this research is to collect blood samples and data from pregnant women who are Rh negative. The blood will be used for the future research and the development of non-invasive prenatal tests to identify Rh blood type status of the baby during pregnancy.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Willing and able to provide written informed consent 2. 18 years of age or older at enrollment 3. Women with a viable pregnancy (with documented fetal heartbeat) between 12 weeks, 0 days and 28 weeks, 0 days gestational age 4. Women with RhD negative antigen status by serology 5. Willing to provide neonatal ABO and RhD genotyping status Exclusion Criteria: 1\. Women with multiple gestation pregnancy

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ochsner Health New Orleans Louisiana

More Devyser Inc. trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06690099 on ClinicalTrials.gov ↗ ← All trials in the USA